Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer – Butlletí de la Recerca

Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer

by biblioteca on 13 d'octubre de 2026 with No hi ha comentaris

Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer
Convoca: Pfizer Inc
Termini: 12/01/2027

Deixa un comentari Cancel·la les respostes